The latest on ER-β in breast cancer

被引：0
|
作者：
Gustafsson, JÅ
Cheng, G
Jensen, E
Palmieri, C
Coombes, C
Warner, M
机构：
[1] Karolinska Inst, Dept Med Nutr, S-14186 Huddinge, Sweden
[2] Karolinska Inst, Dept Biosci, S-14186 Huddinge, Sweden
[3] Univ London Imperial Coll Sci Technol & Med, Sch Med, Canc Res Campaign Labs, Dept Canc Med,Canc Cell Biol Grp, London W12 0NN, England
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [1] Role of ER-α36 in breast cancer by typical xenoestrogens
    Liu, Jun
    Xu, Zhixiang
    Ma, Xiaodong
    Huang, Bin
    Pan, Xuejun
    [J]. TUMOR BIOLOGY, 2015, 36 (10) : 7355 - 7364
  • [2] ER-α variant ER-α36 mediates antiestrogen resistance in ER-positive breast cancer stem/progenitor cells
    Deng, Hao
    Yin, Li
    Zhang, Xin-Tian
    Liu, Li-Jiang
    Wang, Mo-Lin
    Wang, Zhao-Yi
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2014, 144 : 417 - 426
  • [3] Expression of glucose transporter GLUT-1 and estrogen receptors ER-α and ER-β in human breast cancer
    Laudanski, P
    Koda, M
    Kozlowski, L
    Swiatecka, J
    Wojtukiewicz, M
    Sulkowski, S
    Wolczynski, S
    [J]. NEOPLASMA, 2004, 51 (03) : 164 - 168
  • [4] ER-α36, a variant of ER-α, is the estrogen receptor that mediates mitogenic estrogen signaling in breast cancer cells
    Ding, L.
    Zhang, X. T.
    Wang, Z. Y.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 68S - 68S
  • [5] RISK OF ER+ AND ER- BREAST-CANCER - INTERACTION OF MISCARRIAGE HISTORY WITH ER POLYMORPHISM
    LEHRER, S
    HARLAP, J
    RABIN, J
    SCHACHTER, BS
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (11) : S69 - S69
  • [6] AR Is an ER-α Collaborating Factor in Hormone Resistant Breast Cancer
    Rechoum, Yassine
    Rovito, Daniela
    Iacopetta, Domenico
    Barone, Ines
    Ando, Sebastiano
    Ciupek, Andrew
    Weigel, Nancy L.
    Fuqua, Suzanne A.
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [7] Evaluation of ER-α, ER-β1 and ER-β2 expression and correlation with clinicopathologic factors in invasive luminal subtype breast cancers
    Zhang, Huiming
    Zhang, Zhongtao
    Xuan, Lixue
    Zheng, Shan
    Guo, Lei
    Zhan, Qimin
    Qu, Xiang
    Zhang, Baoning
    Wang, Yu
    Wang, Xiang
    Song, Yongmei
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (03): : 225 - 231
  • [8] Evaluation of ER-α, ER-β1 and ER-β2 expression and correlation with clinicopathologic factors in invasive luminal subtype breast cancers
    Huiming Zhang
    Zhongtao Zhang
    Lixue Xuan
    Shan Zheng
    Lei Guo
    Qimin Zhan
    Xiang Qu
    Baoning Zhang
    Yu Wang
    Xiang Wang
    Yongmei Song
    [J]. Clinical and Translational Oncology, 2012, 14 : 225 - 231
  • [9] DAX-1 expression in human breast cancer:: comparison with estrogen receptors ER-α, ER-β and androgen receptor status
    Conde, I
    Alfaro, JM
    Fraile, B
    Ruíz, A
    Paniagua, R
    Arenas, MI
    [J]. BREAST CANCER RESEARCH, 2004, 6 (03) : R140 - R148
  • [10] DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-α, ER-β and androgen receptor status
    Isabel Conde
    Juan M Alfaro
    Benito Fraile
    Antonio Ruíz
    Ricardo Paniagua
    Maria I Arenas
    [J]. Breast Cancer Research, 6
12345